Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Deputy Directors of the MRC Weatherall Institute of Molecular Medicine

Professor Adam Mead is joining Professor Alison Simmons as a Deputy Director of the WIMM in May 2026.

Adam Mead and Alison Simmons

Adam and Alison will work closely with the MRC WIMM Director and the MRC WIMM Administrator to shape the Institute's future direction and success. This enhanced senior leadership team will support the Institute's mission to deliver impactful discoveries in immunology and haematology, by guiding research priorities, securing funding, and enhancing collaboration.

Professor KJ Patel, Director of the MRC WIMM, said: 'Adam's and Alison's expertise, leadership, and dedication to scientific advancement make them ideally suited to help shape the Institute's future.'

Similar stories

Professor KJ Patel awarded Royal Society Buchanan Medal

Congratulations to Professor Patel, who has received the Buchanan Medal, which recognises distinguished contributions to the biomedical sciences.

New pump-priming awards support cross-cutting research across RDM

Five Radcliffe Department of Medicine research teams have secured pump-priming funding to support new collaborations and early-stage research aligned with RDM’s cross-cutting research themes.

First real-world trial shows AI could reduce need for contrast injections in heart MRI scans

The technology could make advanced heart MRI faster, cheaper and more accessible.

Beyond cancer dependency maps: the PRECISE vision

Dr Sumana Sharma is one of the founding partners of a major new pan-European initiative that aims to transform how scientists identify and target cancer's weaknesses, moving beyond simply mapping cancer vulnerabilities towards predicting them before they are experimentally tested.

MRC WIMM achieves Gold Green Impact award

Congratulations to the Institute's Green Impact team, who achieved Gold in the University of Oxford's 2026 Green Impact awards.

New personalised therapy targets chronic blood cancer

A new form of CAR T cell therapy has been designed to find and destroy the cancer-driving cells responsible for a group of blood cancers known as myeloproliferative neoplasms (MPNs), while leaving healthy blood cells unharmed, according to a new study led by UCL and University of Oxford researchers.

Similar stories

Professor KJ Patel awarded Royal Society Buchanan Medal

Congratulations to Professor Patel, who has received the Buchanan Medal, which recognises distinguished contributions to the biomedical sciences.

New pump-priming awards support cross-cutting research across RDM

Five Radcliffe Department of Medicine research teams have secured pump-priming funding to support new collaborations and early-stage research aligned with RDM’s cross-cutting research themes.

First real-world trial shows AI could reduce need for contrast injections in heart MRI scans

The technology could make advanced heart MRI faster, cheaper and more accessible.

Beyond cancer dependency maps: the PRECISE vision

Dr Sumana Sharma is one of the founding partners of a major new pan-European initiative that aims to transform how scientists identify and target cancer's weaknesses, moving beyond simply mapping cancer vulnerabilities towards predicting them before they are experimentally tested.

MRC WIMM achieves Gold Green Impact award

Congratulations to the Institute's Green Impact team, who achieved Gold in the University of Oxford's 2026 Green Impact awards.

New personalised therapy targets chronic blood cancer

A new form of CAR T cell therapy has been designed to find and destroy the cancer-driving cells responsible for a group of blood cancers known as myeloproliferative neoplasms (MPNs), while leaving healthy blood cells unharmed, according to a new study led by UCL and University of Oxford researchers.